Replies to post #233794 on Biotech Values

[IanFromSI]

I also look forward to Dew's response.

Dr. Bhat founded Reviva Pharmaceuticals (Reviva) in 2006 and since its inception, Reviva has advanced extremely rapidly under his leadership, with a portfolio of proprietary compounds at different stages in a pipeline encompassing chronic diseases in large therapeutic areas such as CNS, metabolic, cardiovascular and pain. Dr. Bhat has developed and implemented innovative financing and business models with strategies that have greatly accelerated the drug discovery and development process, resulting in significant savings of time and costs but without sacrificing quality.

After 13 years, Reviva has 0 products approved or being marketed; has not completed nor started a single Ph III trial, has no collaborations with any established Pharmaceutical or Biotech and has no named deep pocketed source of funds. It is difficult to understand how the highlighted statement from the website could be true.

http://revivapharma.com/leadership-4/